A patient with metastatic kidney cancer underwent suction of a cancerous tumor. Physicians at Henry Ford Hospital successfully performed a minimally invasive kidney removal after clearing the tumour. The genetic material from his tumor is under trial to produce a vaccine to help fight his metastatic disease. AngioVac employs large suction catheters to filter blood through a cardiac bypass machine and remove clots, tumors or other foreign material. Craig ...
Read More
You have just read an article categorized health
titled Cancerous Tumor Suctioned and Processed into a Vaccine for Clinical Trials.
Written by:
editor -
Tuesday, February 17, 2015
There are currently no comments for "Cancerous Tumor Suctioned and Processed into a Vaccine for Clinical Trials"
Post a Comment